DIAGNOSTICS + BIOMARKERS

The oral-health signal stack.

Companies and infrastructure turning images, saliva, biomarkers and remote screening into structured information that can move beyond the dental office.

Market map

10 TRACKED
01

AI + Imaging

Denti.AI ↗

Radiograph analysis + clinical documentation

Healthcare use
Structured oral findings
Stage
Commercial
02

AI + Imaging

Orca Dental AI ↗

Radiograph analysis

Healthcare use
Standardized dental imaging findings
Stage
Commercial / regulated product
03

AI + Imaging

CranioCatch ↗

Dental and maxillofacial image analysis

Healthcare use
Machine-readable craniofacial findings
Stage
Commercial
04

Remote Screening

scanO ↗

Smartphone-based oral screening

Healthcare use
Screening beyond the dental office
Stage
Commercial
05

Imaging Infrastructure

DEXIS / Envista ↗

Installed imaging infrastructure

Healthcare use
Distribution rail for oral-health data
Stage
Established infrastructure
06

Imaging Infrastructure

Carestream Dental ↗

Imaging + practice software ecosystem

Healthcare use
Installed base for clinical intelligence
Stage
Established infrastructure
07

Digital Workflow

3Shape ↗

Intraoral scanning + digital workflows

Healthcare use
Structured longitudinal oral data
Stage
Established infrastructure
08

AI + Payer Connectivity

Overjet ↗

Imaging AI + claims review + payer-provider alignment

Healthcare use
Connects diagnostic output to benefits and clinical review workflows
Stage
Scaled commercial infrastructure
09

Interoperability

Kno2 ↗

National health-information exchange infrastructure

Healthcare use
Connects dental records and workflows to broader healthcare exchange
Stage
Production infrastructure
10

Prevention + Engagement

Firstgrin ↗

Maternal and infant oral-health engagement

Healthcare use
Earlier prevention and connection to care in Medicaid populations
Stage
Measured pilot outcomes

MARKET-MAP STANDARD

Clinical utility is the filter.

We track products that create, structure or move an oral-health signal. Inclusion does not imply that a product improves systemic outcomes; evidence and commercial status are tracked separately.